Emerald Bioventures, LLC 13D and 13G filings for Galera Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-27 4:14 pm Purchase | 2026-04-07 | 13D | GALERA THERAPEUTICS INC GRTX | Emerald Bioventures, LLC | 40,216,160 26.500% | 40,216,160 (New Position) | Filing |